B of A Securities Downgrades Ventas to Neutral, Lowers Price Target to $62
B of A Securities analyst Joshua Dennerlein downgrades Ventas (NYSE:VTR) from Buy to Neutral and lowers the price target from $66 to $62.
BTIG Downgrades New Senior Investment Gr to Neutral
BTIG analyst Michael Gorman downgrades New Senior Investment Gr (NYSE:SNR) from Buy to Neutral.
Berenberg Downgrades Sensei Biotherapeutics to Hold, Announces $12 Price Target
Berenberg analyst Zhiqiang Shu downgrades Sensei Biotherapeutics (NASDAQ:SNSE) from Buy to Hold and announces $12 price target.
JP Morgan Downgrades Goosehead Insurance to Neutral, Raises Price Target to $135
JP Morgan downgrades Goosehead Insurance (NASDAQ:GSHD) from Overweight to Neutral and raises the price target from $100 to $135.
Longbow Research Downgrades Polaris to Neutral
Longbow Research analyst David Macgregor downgrades Polaris (NYSE:PII) from Buy to Neutral.
Goldman Sachs Downgrades Bioventus to Neutral, Lowers Price Target to $19
Goldman Sachs analyst Amit Hazan downgrades Bioventus (NASDAQ:BVS) from Buy to Neutral and lowers the price target from $20 to $19.
Deutsche Bank Downgrades BNP Paribas to Hold
Deutsche Bank downgrades BNP Paribas (OTC:BNPQY) from Buy to Hold.
Jefferies Downgrades Partners Group Holding to Hold
Jefferies downgrades Partners Group Holding (OTC:PGPHF) from Buy to Hold.
Credit Suisse Downgrades RISE Education Cayman to Neutral, Lowers Price Target to $2.9
Credit Suisse downgrades RISE Education Cayman (NASDAQ:REDU) from Outperform to Neutral and lowers the price target from $7.5 to $2.9.
Keybanc Downgrades Edison to Sector Weight
Keybanc analyst Sophie Karp downgrades Edison (NYSE:EIX) from Overweight to Sector Weight.